BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT02323113-completion@plaintrial.com
DTSTAMP:20261028T031137Z
DTSTART;VALUE=DATE:20180815
SUMMARY:Safety\, Tolerability\, and Efficacy of TAK-659 in Adults With Rela
 psed or Refractory Acute Myelogenous Leukemia (AML) — estimated completi
 on date
DESCRIPTION:Terminated. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT02323113
URL:https://plaintrial.com/trial/NCT02323113
END:VEVENT
END:VCALENDAR